Infratil [ASX:IFT] Announces NZ$850 Million Equity Raise for One NZ Acquisition
Infratil raises AU$774 million to help fund the acquisition of a 49.9% stake in One NZ, taking its ownership to 9.90%.
Medical Group Polynovo [ASX:PNV] Hits New Record for Monthly Sales
Medical Group Polynovo [ASX:PNV] Hits New Record for Monthly Sales
Medical researcher Polynovo posted a record monthly sale total of $7.2 million in the month of May, led by $5.2 million in the United States with new records also hitting in Canada, Hong Kong, India, and a new order in the Middle East. The group’s total revenue for the 11 months to May rose 54%.
Synlait [ASX:SM1] and A2 [ASX:A2M] Baby Formula Products Officially Approved by New Chinese Standard
Synlait [ASX:SM1] and A2 [ASX:A2M] Baby Formula Products Officially Approved by New Chinese Standard
Synlait and The a2 Milk Company received approval from Chinese authorities for the re-registration of their Chinese label of infant milk formula which is now to be manufactured in line with the country’s regulations, removing any pre-existing anxiety over the issue.
Soul Pattinson [ASX:SOL] Reaches $10.6 Billion in Net Asset Value
Soul Pattinson [ASX:SOL] Reaches $10.6 Billion in Net Asset Value
Washington H Soul Pattinson reports pre-tax year-to-date net asset value of $10.6 billion and said that its net assets had outperformed the All-Ords Accumulation Index in the half year, with 475.7 million in regular group NPAT.
Raiz Invest [ASX:RZI] Shares May’s Snapshot of Active Customers and Funds
Raiz Invest [ASX:RZI] Shares May’s Snapshot of Active Customers and Funds
Fintech Raiz Invest says that despite some continuing market volatility shaking general markets lately, it still managed to reach $1.139.34 million in global FUM for the month ending 31 May.
Homeco Daily Needs [ASX:HDN] REIT Evaluates Properties and Progress
Homeco Daily Needs [ASX:HDN] REIT Evaluates Properties and Progress
Australian real estate trust HomeCo Daily Needs has announced its June 2023 property valuations and talks progress on its accretive developments.
Starpharma’s [ASX:SPL] Viraleze Nasal Spray Receives Approval in Malaysia
Starpharma’s [ASX:SPL] Viraleze Nasal Spray Receives Approval in Malaysia
Biotech Starpharma has received regulatory approval for its Viraleze product to be used in Malaysia, adding the product to a wider market base that now spans 35 countries as it looks into further COVID-19 studies in the UK.
Kelsian [ASX:KLS] Acquires All Abroad America! for $487 Million
Kelsian [ASX:KLS] Acquires All Abroad America! for $487 Million
Ferries and buses tourism group Kelsian has completed a $487 million acquisition of All Aboard America! Holdings (AAAHI) first announced in March.
Bubs Talks [ASX:BUB] Trade in the US and China as Founder War Brews
Bubs Talks [ASX:BUB] Trade in the US and China as Founder War Brews
Bubs has provided a short trading update in the wake of some media speculation encircling former CEO and founder Kristy Carr, who was said to have been creating a stir after the group ousted her and Chairman Dennis Lin.
Lynch Group [ASX:LGL] Takes a Boost in Earnings for 2023
Lynch Group [ASX:LGL] Takes a Boost in Earnings for 2023
Flower seller Lynch Group has upped its earnings guidance for the full year fiscal 2023, with expectations of revenue increasing 5% on a stronger performance in sales and returning of stores.
